Genomes and Genes

Species

Heleen M den Hertog

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. den Hertog H, van der Worp H, van Gemert H, Algra A, Kappelle L, van Gijn J, et al. Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]. BMC Cardiovasc Disord. 2008;8:29 pubmed publisher
    ..The protocol change was initiated because of both advances in statistical approaches and to increase the efficiency of the trial by improving statistical power. Current Controlled Trials [ISCRTN74418480]. ..
  2. den Hertog H, van der Worp H, van Gemert H, Algra A, Kappelle L, van Gijn J, et al. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 2009;8:434-40 pubmed publisher
    ..Paracetamol might have a beneficial effect on functional outcome in patients admitted with a body temperature 37-39 degrees C, but this post-hoc finding needs further study. Netherlands Heart Foundation. ..
  3. den Hertog H, van Rossum J, van der Worp H, van Gemert H, de Jonge R, Koudstaal P, et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol. 2009;256:2003-8 pubmed publisher
    ..7, 95% CI 1.0–2.9) at 3 months. In addition, the risk of poor outcome or death at 3 months increased with higher levels of CRP. CRP within 12 h of ischemic stroke is an independent prognostic factor of poor outcome at 3 months. ..

Detail Information

Publications3

  1. den Hertog H, van der Worp H, van Gemert H, Algra A, Kappelle L, van Gijn J, et al. Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]. BMC Cardiovasc Disord. 2008;8:29 pubmed publisher
    ..The protocol change was initiated because of both advances in statistical approaches and to increase the efficiency of the trial by improving statistical power. Current Controlled Trials [ISCRTN74418480]. ..
  2. den Hertog H, van der Worp H, van Gemert H, Algra A, Kappelle L, van Gijn J, et al. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 2009;8:434-40 pubmed publisher
    ..Paracetamol might have a beneficial effect on functional outcome in patients admitted with a body temperature 37-39 degrees C, but this post-hoc finding needs further study. Netherlands Heart Foundation. ..
  3. den Hertog H, van Rossum J, van der Worp H, van Gemert H, de Jonge R, Koudstaal P, et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol. 2009;256:2003-8 pubmed publisher
    ..7, 95% CI 1.0–2.9) at 3 months. In addition, the risk of poor outcome or death at 3 months increased with higher levels of CRP. CRP within 12 h of ischemic stroke is an independent prognostic factor of poor outcome at 3 months. ..